These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
448 related items for PubMed ID: 22915052
1. Post-transplant lymphoproliferative disease of donor origin, following haematopoietic stem cell transplantation in a patient with blastic plasmacytoid dendritic cell neoplasm. Piccin A, Morello E, Svaldi M, Haferlach T, Facchetti F, Negri G, Vecchiato C, Fisogni S, Pusceddu I, Cortelazzo S. Hematol Oncol; 2012 Dec; 30(4):210-3. PubMed ID: 22915052 [Abstract] [Full Text] [Related]
2. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder. Patel JL, Shetty S, Salama ME. Am J Dermatopathol; 2011 May; 33(3):e31-6. PubMed ID: 20861710 [Abstract] [Full Text] [Related]
3. Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation. Liu QF, Fan ZP, Luo XD, Sun J, Zhang Y, Ding YQ. Transpl Infect Dis; 2010 Aug 01; 12(4):284-91. PubMed ID: 20345506 [Abstract] [Full Text] [Related]
4. [Epstein-Barr virus-associated post-transplant lymphoproliferative disorder diagnosed by the episode of intestinal perforation following allogeneic hematopoietic stem cell transplantation]. Aimoto M, Yamane T, Inoue A, Momose D, Moriguchi-Aimoto R, Wada-Inoue E, Okamoto S, Koh H, Nakane T, Takeoka Y, Akahori-Nakamae M, Nishiki-Kosaka S, Terada Y, Nakamae H, Koh KR, Nakao T, Ohsawa M, Hino M. Rinsho Ketsueki; 2010 Dec 01; 51(12):1775-80. PubMed ID: 21258188 [Abstract] [Full Text] [Related]
5. Heterogeneity in clinical course of EBV-associated lymphoproliferative disorder after allogeneic stem cell transplantation. Meyer SC, Medinger M, Halter JP, Baldomero H, Hirsch HH, Tzankov A, Dirnhofer S, Passweg JR, Tichelli A. Hematology; 2014 Jul 01; 19(5):280-5. PubMed ID: 24074746 [Abstract] [Full Text] [Related]
6. [Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation]. Liu QF, Fan ZP, Luo XD, Zhang Y, Sun J. Zhonghua Yi Xue Za Zhi; 2008 Dec 02; 88(44):3123-6. PubMed ID: 19159594 [Abstract] [Full Text] [Related]
7. Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases. Styczynski J, Einsele H, Gil L, Ljungman P. Transpl Infect Dis; 2009 Oct 02; 11(5):383-92. PubMed ID: 19558376 [Abstract] [Full Text] [Related]
13. [The efficacy and safety of donor lymphocyte infusion to treat Epstein-Barr virus associated lymphoproliferative diseases after allogeneic hematopoietic stem cell transplantation]. Xu LP, Liu DH, Liu KY, Chen H, Han W, Wang Y, Wang J, Shi HX, Huang XJ. Zhonghua Nei Ke Za Zhi; 2010 Nov 02; 49(11):955-8. PubMed ID: 21211211 [Abstract] [Full Text] [Related]
14. Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation. Ruf S, Behnke-Hall K, Gruhn B, Bauer J, Horn M, Beck J, Reiter A, Wagner HJ. J Clin Virol; 2012 Mar 02; 53(3):186-94. PubMed ID: 22182950 [Abstract] [Full Text] [Related]